LCA showed the highest BDI index for the inhibition of the OATP4C1-mediated T3 uptake of the three bile acids; thus, LCA–drug interaction via the renal drug transporter OATP4C1 may occur in patients with liver failure. The gene discussed is SLCO4C1; the disease is liver failure.